Yale University; School of Medicine; AIDS Program

New Haven, Connecticut 06520

0 studies enrolling now · 9 studies all time

What they study most

AIDS, Acquired Immunodeficiency Syndrome, HIV Infections, HIV Pre-exposure Prophylaxis, HIV-1 Infection, HIV-1-Infection, HIV-1-infection, Human Immunodeficiency Virus, Opioid-Related Disorders

Studies at this site

• Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) — Running, not enrolling
• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 — Running, not enrolling
• A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection — Running, not enrolling
• Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen — Running, not enrolling
• Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection — Completed
• Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
• Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir — Completed
• Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment — Completed
• Buprenorphine and Integrated HIV Care Evaluation — Status unconfirmed